Smart partnership to find IBD treatments

Israel’s CytoReason (see here previously) is partnering France’s Sanofi to identify novel therapies to treat Inflammatory Bowel Disease (IBD). Sanofi will pay CytoReason millions of dollars to use the Israeli startup’s computational AI-discovery disease model platform.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *